View Pages
Deere raises profit outlook; Moderna trims gains after cancer‑vaccine trial news; crypto-linked stocks surge as Bitcoin rallies and executives meet President Trump.
Editorial companion
Deere shares moved higher in premarket trade after the company tightened its annual net income range, Moderna pared gains after a late-stage melanoma vaccine success tied to Merck's Keytruda, and crypto-linked names jumped as Bitcoin's rally forced record short liquidations. The trio shows three ways markets move before the bell: guidance revisions, binary biotech trial news, and macro-driven speculative squeezes. For active investors, the episode is a clear reminder that headlines can reprice risk across sectors in a single premarket session.
View Pages
View Pages
View Pages